### Thesis Topic: Estimating the Effectiveness of Non-Pharmaceutical Interventions (NPIs) During COVID-19

Worldwide, governments imposed a wide range of non-pharmaceutical interventions (NPIs) in the wake of the COVID-19 pandemic. Three years later today, pandemic fatigue has set in among the worldâ€™s population as the virus attack continues in waves. To help governments contain the pandemic more effectively and to ease the burden on the population, we examined the effectiveness of individual NPI among the 42 states in the US where death count exceeded 100 during the first wave of the COVID-19 pandemic (February 1 to June 15, 2020). Two types of analyses were performed. Firstly, a prototypical Bayesian hierarchical model is employed to estimate the effectiveness of 5 commonly imposed NPIs in the US, including *gathering restriction*, *restaurant capacity restriction*, *business closure*, *school closure*, and *stay-at-home*. Secondly, the effectiveness of *facemask mandate*, the most controversial policy among states, is studied through counterfactual modeling, a variant of the prototypical Bayesian hierarchical model.

![US Map](./images/NPI/US_States.png)
The colored states are the 42 states whose death count had exceeded 100 by the end of the study period where the grey states were the ones excluded from the analysis due to low death count.The 14 green states implemented facemask mandate policy during the study period where the 28 pink states did not implement facemask mandate policy during the study period.

**Result Visulizations (generated using ggplot in R):**
* [The effectiveness of 5 commonly imposed NPIs](https://github.com/lyh07749/Yuhang_Liu_Profile/blob/main/images/NPI/NPI_Rt_Reduction.png) (represented by the percentage reduction on Rt)
* [The estimated Rt trajectory for Massachusets](https://github.com/lyh07749/Yuhang_Liu_Profile/blob/main/images/NPI/Massachusetts_Rt.png) (all 42 states are available but only present one for illustration purpose)
* [The estimated (orange) and observed (brown) infections and deaths for Massachusets](https://github.com/lyh07749/Yuhang_Liu_Profile/blob/main/images/NPI/Massachusetts_Infection_Death.png) 
* [Median time-varying reproduction number estimates for states with and without facemask mandate](https://github.com/lyh07749/Yuhang_Liu_Profile/blob/main/images/NPI/Mask_Rt_Estimates.png)
* [Daily infection estimates for states with and without facemask mandate](https://github.com/lyh07749/Yuhang_Liu_Profile/blob/main/images/NPI/Mask_Infection_Estimates.png)
* [Daily death estimates for states with and without facemask mandate](https://github.com/lyh07749/Yuhang_Liu_Profile/blob/main/images/NPI/Mask_Death_Estimates.png)

### Project 1: COVID-19 Survival Model Comparasion

**Study Period:** March 2020 to December 2020
**Data:** the data originated from Stony Brook Medicine and were received in raw as csv files. 
* The **first raw EMR data file (dim: 3535 * 168)** contains the patient demographics data, including but not limited to mrn, encounter number, admission date, discharge date, age, gender, race, ethnicity, symtoms (cough, sore throat, etc.), pre-exisisting conditions (heart failure, COPD, CHD, etc.), and patient vital status. Most of the patients have only one encounter during the study period, but there's still some patients have multiple encounters. If this is the case, we select the most recent COVID-19 related encounter.
* The **second raw EMR data file (dim: 1048571 * 10)** contains 26 measured biomarkers, including but not limited to ALT, AST, Creatinine, C-Reactive Protein, etc. The lab will only measure the biomarkers which the physician considered necessary for the patient. The physician may start/stop asking measure a particular biomarker at any time during a patient's hospital stay. If necessary, one biomarker might being measured multiple times for the same patient within the same day.

[Sample Biomarker Data](https://github.com/lyh07749/Yuhang_Liu_Profile/blob/main/data_files/Covid_Survival_Models/sample%20biomarker%20data.csv)
